4 Topic Commentaries
Timing of Stage 2 ROP May Help Identify High-Risk Eyes
-
Gil Binenbaum, MD, MSCE
Pediatric ophthalmology; Retinopathy of prematurity (ROP)
•Children’s Hospital of Philadelphia
SourceWe developed a new set of criteria that appeared to more accurately predict ROP.
-
Darius M. Moshfeghi, MD
Retina; ROP telemedicine and screening
•Stanford University, Byers Eye Institute
SourceIf you screen babies in a timely fashion, there should be no infant that goes blind from this disease — that’s our premise.
-
Neil Bressler, MD
Retina; Pediatric retinal disease
•Wilmer Eye Institute, Johns Hopkins Medicine
Sourcethese treatments are only effective if you know which premature infants need treatment.
-
Robert J. Hardy, PhD
Biostatistics; Ophthalmic clinical trials (ROP)
•The University of Texas School of Public Health, Houston
SourceAdditional research is needed to identify still better methods for the prevention and treatment of severe ROP.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







